Dongkyoon Kim is a biotech founder and CEO with 20+ years of hands-on experience in biologics discovery and development for oncology, rare diseases, and chronic kidney conditions. He combines deep academic training—a Ph.D. in Molecular Biology & Immunology from UT Austin and postdoctoral work at Stanford—with operational leadership building discovery platforms, antibody development workflows, and immunology/cell biology teams. As Co-Founder and Head of Discovery at multiple startups and now leading an AI-guided complement inhibitor company, he blends wet-lab rigor with data-driven, AI-enabled hit validation strategies. He has overseen everything from target identification and immune repertoire capture to translational in vivo studies, demonstrating a rare span from molecular mechanism to early development. Based in Seoul but operating with a U.S.-trained research pedigree, he’s comfortable navigating both academic and startup ecosystems while fundraising for pre-seed/seed milestones. A pragmatic scientist with an entrepreneur’s drive, he quietly signals risk-awareness with the motto “escape boiling frog,” reflecting his emphasis on timely adaptation.
8 years of coding experience
25 years of employment as a software developer
Ph.D, Molecular Biology and Immunology, Ph.D, Molecular Biology and Immunology at The University of Texas at Austin
MS, Genetic Science, MS, Genetic Science at Kyungpook National University
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.